Refining the telomere-telomerase hypothesis of aging and cancer

Nature Biotechnology

Volumn 14, Issue 7, 1996, Pages 836-839

  Holt, Shawn E ^a   Shay, Jerry W ^a   Wright, Woodring E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Immortalization; Proliferation; Quiescence; Senescence; Stem cells

Indexed keywords

ANTINEOPLASTIC AGENT; CELL ENZYME; ENZYME INHIBITOR; TELOMERASE; TELOMERASE INHIBITOR; UNCLASSIFIED DRUG;

ADULT; CANCER; CANCER DIAGNOSIS; CELL AGING; CELL CYCLE; CELL IMMORTALIZATION; CHILD; CHILDHOOD CANCER; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NEUROBLASTOMA; PRIORITY JOURNAL; REVIEW; SENESCENCE; SOLID TUMOR; STEM CELL; TELOMERE; TUMOR CELL CULTURE;

AGING; CELL TRANSFORMATION, NEOPLASTIC; ENZYME INHIBITORS; HUMANS; LYMPHOCYTES; NEOPLASMS; STEM CELLS; TELOMERASE; TELOMERE;

EID: 0029895383     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0796-836     Document Type: Article

References (48)

1. Harley, C.B., Futcher, A.B., and Greider, C.W. 1990. Telomeres shorten during aging. Nature 345:455-460.
2. Counter, CM., Avilion, A.A., LeFeuvre, C.E., Stewart, N.G., Greider, C.W., Harley, C.B., and Bacchetti, S. 1992. Telomere shortening associated with chromosome instability is arrested in immortal cells which express talomerase activity. EMBOJ. 11:1921-1929.
3. Shay, J.W., Werbin, H., and Wright, W.E. 1995. You haven’t heard the end of it: telomere loss may link human aging with cancer. Canad. J. Aging 14:511-524.
4. Counter, CM., Gupta, J., Harley, C.B., Leber, B., and Bacchetti, S. 1995. Telomerase activity in normal leukocytes and in hematologic malignancies. Stood 85:2315-2320.
5. Hiyama, E., Hiyama, K., Yokoyama, T, Matsuura, Y., Piatyszek, M.A., and Shay, J.W. 1995. Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med. 1:249-255.
6. Hiyama, K., Hirai, Y., Kyoizumi, S., Akiyama, M., Hiyama, E., Piatyszek, MA, Shay, J.W., Ishoika, S., and Yamakido, M. 1995. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol. 155:3711-3715.
7. Hiyama, K., Hiyama, E., Ishoika, S., Yamakido, M., Inai, K., Gazdar, A.F., Piatyszek, M.A., and Shay, J.W. 1995. Telomerase activity in small-cell and non-small-cell lung cancers. J. Natl. Cancer Inst. 87:895-902.
8. Hiyama, E., Yokoyama, T, Tatsumoto, N., Hiyama, K., Imamura, Y., Murakami, Y., Kodama, T, Piatyszek, M., Shay, J.W., and Matsuura, Y. 1995. Telomerase activity in gastric cancer. Cancer Res. 55:3258-3262.
9. Hiyama, E., Gollahon, L, Kataoka, T., Kuroi, K., Yokoyama, T, Gazdar, A.F, Hiyama, K., Piatyszek, MA, and Shay, J.W. 1996. Telomerase activity in human breast tumors. J. Natl. Cancer Inst 88:116-122.
10. Kim, N.W., Piatyszek, M.A., Prowse, K.R., Harley, C.B., West, M.D., Ho, P.L.C., Covieilo, G.M., Wright, W.E, Weinrich, S.L, and Shay, J.W. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015.
11. Piatyszek, M.A., Kim, N.W., Weinrich, S.L., Hiyama, K., Hiyama, E., Wright, W.E., and Shay, J.W. 1995. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods CellSci. 17:1-15.
12. Dix, D. 1989. The role of aging in cancer incidence: an epidemiological study. J. Geron. Biol. Sci. 44:10-18.
13. Peto, R, Roe, F.J.C., Lee, P.N., Levy, L, and Clack, J. 1975. Cancer and ageing in mice and men. Brit J. Cancer 32:411-426.
14. Blackburn, E.H. 1994. Telomeres: No end in sight. Cell 77:21-623.
15. Greider, C.W. 1995. Mammalian telomere dynamics: healing fragmentation shortening and stabilization. Curr. Opin. Genet and Dev. 4:203-211.
16. Levy, M.Z., Allsopp, R.C., Futcher, A.B., Greider, C.W., and Hariey, C.B. 1992. Telomere end-replication problem and cell aging. J. Mol. Biol. 225:951-960.
17. Wright, W.E. and Shay, J.W. 1992. The two-stage mechanism controlling cellular senescence and immortalization. Exp. Geron. 27:383-389.
18. Shay, J.W., Pereira-Smrth, O., and Wright, W.E. 1991. A role for both Rb and p53 in the regulation of cellular senescence. Exp. Cell Res. 196:33-39.
19. Hayflick, L. 1965. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37:614-636.
20. Holt, S.E., Wright, W.E., and Shay, J.W. 1996. Regulation of telomerase activity in immortal cell lines. Molec. Cell. Biol. 16:2932-2939.
21. Sharma, H.W., Sokoloski, J.A., Perez, J.R., Maltese, J.Y., Sartorelli, A.C., Stein, C.A., Nichols, G., Khaled, Z., Teiang, N.T., and Narayanan, R. 1995. Differentiation of immortal cells inhibits telomerase activity. Proc. Natl. Acad. Sci. USA 92:12343-12346.
22. Wright, W.E., Piatyszek, M.A., Rainey, W.E., Byrd, W. and Shay, J.W. 1996. Telomerase activity in human germline and embryonic tissues and cells. Devel. Genet. 18:173-179.
23. Mantell, L.L and Greider, C.W. 1994. Telomerase activity in germline and embryonic cells of Xenopus. EMBO J. 13: 3211-3217.
24. Zhang, W., Piatyszek, MA, Kobayashi, T, Estey, E., Andreeff, M., Deisseroth, A.B., Wright, W.E., and Shay, J.W. 1996. Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents. Clin. Cancer Res. 2:799-803.
25. Hastie, N.D., Dempster, M., Dunlop, M.G., Thompson, A.M., Green, O.K., and Allshire, R.C 1990. Telomere reduction in human colorectal carcinoma and with ageing. Nature 346:866-868.
26. Vaziri, H., Dragowska, W., Allsopp, R.C, Thomas, T.E., Harley, C.B., and Lansdorp, P.M. 1994. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc. Natl. Acad. Sci. USA 91:9857-9860.
27. Taylor, R.S., Ramirez, R.D., Ogoshi, M., Chaffins, M., Piatyszek, MA, and Shay, J.W. 1996. Detection of telomerase activity in malignant and nonmalignant skin conditions. J. Invest. Dermatol. 106:759-765.
28. Broccolli, D., Young, J.W., and de Lange, T. 1995. Telomerase activity in normal and malignant hematopoietic cells. Proc. Natl. Acad. Sci. USA 92. 9082-9086.
29. Bryan, T.M., Englezou, A., Gupta, J., Bacchetti, S., and Reddel, R. R. 1995. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J. 14:4240-4248.
30. Murnane, J.P., Sabatier L., Marder, B.A., and Morgan, W.F. 1994. Telomere dynamics in an Immortal human cell line. EMBO J. 13:4953-4962.
31. Lundblad, V. and Szostak, J.W. 1989. A mutant with a defect in telomere elongation leads to senescence in yeast. Cell 57:633-643.
32. Singer, M.S. and Gottschling, D.E. 1994. TLC1: template RNA component of Saccharomyces cerevisiae telomerase. Science 266:404-409.
33. McEachern, M.J. and Blackburn, E.H. 1995. Runaway telomere elongation caused by telomerase RNA gene mutations. Nature 376:403-409.
34. Steiner, B.R., Hidaka, K., and Futcher, B. 1996. Association of the est1 protein with telomerase activity in yeast. Proc. Natl. Acad. Sci. USA 932:817-2821.
35. Lundblad, V. and Blackburn, E.H. 1993. An alternate pathway for yeast telomere maintenance rescues est1-senescence. Cell 73:347-360.
36. Hiyama, E., Yokoyama, T, Hiyama, K., Yamakido, M., Santo, T, Kodama, T., Ichikawa, T, and Matsuura, Y. 1994. Alteration of telomeric repeat length in adult and childhood solid neoplasias. Int. J. Oncol. 6:13-16.
37. Greaves, M. 1996. Telomerase activation, stem cells and cancer. Trends Genet. 12:127-128.
38. Shay, J.W. and Wright, W.E. 1996. The reactivation of telomerase activity in cancer progression. Trends Genet. 12:129-131.
39. Hooper, M.L. 1994. The role of p53 and Rb-1 genes in cancer, development and apoptosis. J. Cell Sci. 18:(suppl.)13-17.
40. Hiyama, K., Ishioka, S., Shirotani, Y., Inai, K., Hiyama, E., Murakami, I., Isobe, T., Inamizu, T, and Yamakido, M. 1992. Alterations in telomeric repeat length in lung cancer are associated with loss of heterozygosity in p53 and pRB. Oncogene 10:937-944.
41. Wynford-Thomas, D., Bond, J.A., Wyllie, FS, and Jones, CJ. 1995. Does telomere shortening drive selection for p53 mutation in human cancer? Molec Carcino. 12:119-23.
42. Feng, J., Funk, W.D., Wang, S-S., Weinrich, S.L, Avilion, A.A., Chiu, C-P, Adams, R.R., Chang, E., Allsopp, R.C, Yu, J., Le, S., West, M.D., Harley, C.B., Andrews, W.H., Greider, C.W., and Villeponteau, B. 1995. The RNA component of human telomerase. Science 269:1236-1241.
43. Avilion, A.A., Piatyszek, M.A., Gupta, J., Shay, J.W., Bacchetti, S., and Greider, C.W. 1996. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res. 56:645-650.
44. Blasco, MA, Rizen, M., Greider, C.W., and Hanahan, D. 1996. Differential regulation of telomerase activity and telomerase RNA during multi-stage-tumorigenesis. Nature Genet., 12:200-204.
45. Wright, W.E., Shay, J.W., and Piatyszek, M.A. 1995. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nuc. Acids Res. 23:3794-3795.
46. Shay, J.W. 1995. Aging and cancer: Are telomeres and telomerase the connection? Mol. Med. Today 1:378-384.
47. Shay, J.W. and Wright, W.E 1996. Telomerase activity in human cancer. Curr. Opin. Oncol. 8:65-71.
48. Shay, J.W., Werbin, H., and Wright, W.E. 1996. Telomeres and telomerase in human leukemias. Leukemia. In press.